Image of the Day: Muting Muscle Spasms

Nimodipine, a drug used to treat brain hemorrhages, alleviates spasticity in mice after spinal cord injuries.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: Calcium channels, labeled green in sections of the mouse spinal cord, are blocked by nimodipine, which eases muscle spasms following injury.
M. MARCANTONI ET AL., SCIENCE TRANSLATIONAL MEDICINE (2020)

People with spinal cord injuries often develop muscle spasms that are difficult to treat. After looking into the mechanisms of this post-injury spasticity in mice, the authors of a paper published on April 15 in Science Translational Medicine determined that calcium channels in the spinal cord seem to play a role.

A six-week course of nimodipine, a calcium channel blocker approved to treat brain hemorrhage, administered immediately after mice sustained injuries to their spinal cords prevented muscle spasms. The effects remained even after the treatment ended, suggesting that inhibiting calcium channels may offer a potential way to alleviate one debilitating consequence of spinal cord injuries.

M. Marcantoni et al., “Early delivery and prolonged treatment with nimodipine prevents the development of spasticity ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Amy Schleunes

    A former intern at The Scientist, Amy studied neurobiology at Cornell University and later earned her MFA in creative writing from the University of Iowa. She is a Los Angeles–based writer, editor, and communications strategist who collaborates on nonfiction books for Harper Collins and Houghton Mifflin Harcourt, and also teaches writing at Johns Hopkins University CTY. Her favorite projects involve sharing the insights of science and medicine.

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours